ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
Share · US00650F1093 · ADPT · A2PLR5 (XNAS)
Overview Financial Indicators
10,32 USD
2,28 % 0,23 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 08:17

Current Prices from ADAPTIVE BIOTECHNOLOGIESLOGIES CORP

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ADPT
USD
09.06.2025 08:17
10,32 USD
10,09 USD
+2,28 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
2,28 % 8,06 % 11,33 % 40,41 % 64,59 % 185,87 % -73,82 %

Company Profile for ADAPTIVE BIOTECHNOLOGIESLOGIES CORP Share

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Invested Funds

The following funds have invested in: ADAPTIVE BIOTECHNOLOGIESLOGIES CORP invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
182,24
Percentage (%)
0,43 %

Company Data

Name ADAPTIVE BIOTECHNOLOGIESLOGIES CORP
Company Adaptive Biotechnologies Corporation
Symbol ADPT
Website https://www.adaptivebiotech.com
Primary Exchange XNAS NASDAQ
WKN A2PLR5
ISIN US00650F1093
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Chad M. Robins M.B.A.
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees 0,6 T
Address 1165 Eastlake Avenue East, 98109 Seattle
IPO Date 2019-06-27

Ticker Symbols

Name Symbol
Frankfurt 1HM.F
NASDAQ ADPT

More Shares

Investors who ADAPTIVE BIOTECHNOLOGIESLOGIES CORP hold also have the following shares in their portfolio:
ABBOTT LABORATORIES INC
ABBOTT LABORATORIES INC Share
BASF SE
BASF SE Share
BIONTECH SE ADR
BIONTECH SE ADR Share
ILLUMINA INC
ILLUMINA INC Share
INTELLIA THERAPEUTICSCS INC
INTELLIA THERAPEUTICSCS INC Share
INTL FIN. CORP 2023
INTL FIN. CORP 2023 Bond
LPKF LASER+ELECTRON.
LPKF LASER+ELECTRON. Share
PING AN HEALTHCARE+TECHNOLOGIES
PING AN HEALTHCARE+TECHNOLOGIES Share
ROCHE HOLDING AG
ROCHE HOLDING AG Share
SAP SE
SAP SE Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
XTR.H.M.C.T.100 1CDLA
XTR.H.M.C.T.100 1CDLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025